Zdrowie i gospodarka · 16/02/2011

FDA Releases Draft Guidance for Pharmacoepidemiologic Safety Studies Using Electronic Healthcare Data Sets

The Food and Drug Administration (FDA) has made available a draft guidance document outlining best practices for conducting and reporting pharmacoepidemiologic safety studies using electronic healthcare data sets, with the aim of improving the quality and consistency of such studies.